Key result
AS-IV-stimulated MSC-Exo improved myocardial contractile function, myocardial fibrosis and angiogenesis, reduced inflammatory factors and induced apoptosis in rats after acute myocardial infarction.
Why the study?
It was not entirely clear whether astragaloside IV can improve acute myocardial infarction by inducing bone marrow mesenchymal stem cells-derived exosomes.
Does Astragaloside IV-mediated MSC-Exo improve cardiac function and reduce pathological damage in acute myocardial infarction models?
Does Astragaloside IV-mediated MSC-Exo improve cardiac function and reduce pathological damage in acute myocardial infarction models?
Astragaloside IV enhances the cardioprotective effects of MSC-derived exosomes in acute myocardial infarction models by promoting angiogenesis and reducing inflammation.
Answers are grounded in this paper and cite their sources.
May enhance angiogenesis in rat AMI models; leaves open human translation.
Bone marrow mesenchymal stem cells (BMECs)-derived exosomes (MSC-Exo) can improve acute myocardial infarction (AMI). Astragaloside IV (AS-IV) has also been reported to have cardioprotective pharmacological effects. However, it is not entirely clear whether AS-IV can improve AMI by inducing MSC-Exo. BMSCs and MSC-Exo were isolated and identified, and we also established the AMI rat model and the OGD/R model with H9c2 cells. After MSC-Exo or AS-IV-mediated MSC-Exo treatment, cell angiogenesis, migration, and apoptosis were evaluated by tube formation, wound healing, and TUNEL staining. The cardiac function of the rats was measured by echocardiography. The pathological changes and collagen deposition in rats were also assessed with Masson and Sirius red staining. The levels of α-SMA, CD31 and inflammatory factors were determined by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). In vitro, AS-IV-mediated MSC-Exo can significantly enhance the angiogenesis and migration of H9c2 cells induced by OGD/R, and significantly reduce their apoptosis. In vivo, AS-IV-mediated MSC-Exo can improve the cardiac function of rats, and attenuate pathological damage and collagen deposition in AMI model rats. In addition, AS-IV-mediated MSC-Exo can also promote angiogenesis and reduce inflammatory factors in rats with AMI. AS-IV-stimulated MSC-Exo can improve myocardial contractile function, myocardial fibrosis and angiogenesis, reduce inflammatory factors and induce apoptosis in rats after AMI.
No takes yet. Share an insight, caveat, or question.
Sha et al. (2023) studied Acute myocardial infarction. Astragaloside IV (AS-IV)-mediated MSC-Exo vs. MSC-Exo alone or control was evaluated on Cardiac function, pathological damage, collagen deposition, angiogenesis, inflammatory factors, and apoptosis. AS-IV-stimulated MSC-Exo improved myocardial contractile function, myocardial fibrosis and angiogenesis, reduced inflammatory factors and induced apoptosis in rats after acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: